Cargando…

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

In line with SARS and MERS, the SARS-CoV-2/COVID-19 pandemic is one of the largest challenges in medicine and health care worldwide. SARS-CoV-2 infection/COVID-19 provides numerous therapeutic targets, each of them promising, but not leading to the success of therapy to date. Neither an antiviral no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaess, Markus, Kaiser, Lars, Sauer, Martin, Csuk, René, Deigner, Hans-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404102/ https://www.ncbi.nlm.nih.gov/pubmed/32668803 http://dx.doi.org/10.3390/ijms21144953

Ejemplares similares

Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19
por: Blaess, Markus, et al.
Publicado: (2021)

Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
por: Blaess, Markus, et al.
Publicado: (2020)

Drug triggered pruritus, rash, papules, and blisters – is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin?
por: Blaess, Markus, et al.
Publicado: (2021)

Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways
por: Kaiser, Lars, et al.
Publicado: (2020)

Lysosomal adaptation: How cells respond to lysosomotropic compounds
por: Lu, Shuyan, et al.
Publicado: (2017)

Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy
por: Blaess, Markus, et al.
Publicado: (2019)

Lineage-Selective Disturbance of Early Human Hematopoietic Progenitor Cell Differentiation by the Commonly Used Plasticizer Di-2-ethylhexyl Phthalate via Reactive Oxygen Species: Fatty Acid Oxidation Makes the Difference
por: Kaiser, Lars, et al.
Publicado: (2021)

A Fluorescence-Based Competitive Antibody Binding Assay for Kynurenine, a Potential Biomarker of Kidney Transplant Failure
por: Borgolte, Max, et al.
Publicado: (2022)

The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent N-dodecylimidazole
Publicado: (1987)

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
por: Stark, Michal, et al.
Publicado: (2020)

Cell killing by lysosomotropic detergents
Publicado: (1983)

The Contribution of Lysosomotropism to Autophagy Perturbation
por: Ashoor, Roshan, et al.
Publicado: (2013)

Mitocanic Di- and Triterpenoid Rhodamine B Conjugates
por: Hoenke, Sophie, et al.
Publicado: (2020)

Challenges in Bone Tissue Regeneration: Stem Cell Therapy, Biofunctionality and Antimicrobial Properties of Novel Materials and Its Evolution
por: Riester, Oliver, et al.
Publicado: (2020)

The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in Trypanosoma brucei
por: Koh, Hazel X., et al.
Publicado: (2015)

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
por: Zhitomirsky, Benny, et al.
Publicado: (2018)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

n-Propyl 6-amino-2,6-dideoxy-2,2-difluoro-β-d-glucopyranoside is a good inhibitor for the β-galactosidase from E. coli
por: Serbian, Immo, et al.
Publicado: (2021)

Lysosomotropism depends on glucose: a chloroquine resistance mechanism
por: Gallagher, Laura E, et al.
Publicado: (2017)

Concise Synthesis of Both Enantiomers of Pilocarpine
por: Schmidt, Theresa, et al.
Publicado: (2021)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

The lysosomotrope GPN mobilises Ca(2+) from acidic organelles
por: Yuan, Yu, et al.
Publicado: (2021)

A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
por: Carbó, José M., et al.
Publicado: (2023)

Image‐Based Morphological Profiling Identifies a Lysosomotropic, Iron‐Sequestering Autophagy Inhibitor
por: Laraia, Luca, et al.
Publicado: (2020)

Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2
por: Zhao, Zhuangzhuang, et al.
Publicado: (2021)

QSAR Models for Predicting Five Levels of Cellular Accumulation of Lysosomotropic Macrocycles
por: Norinder, Ulf, et al.
Publicado: (2019)

Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
por: He, Weifeng, et al.
Publicado: (2022)

Potential Antiviral Strategy Exploiting Dependence of SARS-CoV-2 Replication on Lysosome-Based Pathway
por: Lan, Yungang, et al.
Publicado: (2022)

Interactions of the Lysosomotropic Detergent O-Methyl-Serine Dodecylamide Hydrochloride (MSDH) with Lipid Bilayer Membranes—Implications for Cell Toxicity
por: Villamil Giraldo, Ana-Maria, et al.
Publicado: (2020)

Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents
por: Aliwaini, Saeb, et al.
Publicado: (2021)

Methacryloyl-GlcNAc Derivatives Copolymerized with Dimethacrylamide as a Novel Antibacterial and Biocompatible Coating
por: Borgolte, Max, et al.
Publicado: (2021)

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
por: Degtyarev, Michael, et al.
Publicado: (2008)

Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines
por: Zhang, Xinyuan, et al.
Publicado: (2008)

Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death
por: Kondratskyi, A, et al.
Publicado: (2014)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
por: Norinder, Ulf, et al.
Publicado: (2020)

Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies
por: Korolenko, Tatiana A., et al.
Publicado: (2020)

Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
por: Tian, Ai-Ling, et al.
Publicado: (2021)

Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
por: Schätzl, Teresa, et al.
Publicado: (2021)

Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance
por: Rentschler, Simone, et al.
Publicado: (2021)

Challenges in biobanking in personalized medicine – a biobank society’s view
por: Deigner, Hans-Peter
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o14f12lo4ui12n4vor21bmiumh